Point72 Middle East FZE’s Labcorp LH Stock Holding History

Point72 Middle East FZE’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-931	Closed	-$184K	–	1837
2023 Q1	$184K	Sell	931 -117	-11%	-$24.1K	0.01%	966
2022 Q4	$212K	Buy	+1,048	New	+$205K	0.01%	1031

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Point72 Middle East FZE's LH Position: Q2 2023 in Review

Point72 Middle East FZE sold out of Labcorp (LH) in Q2 2023, closing a stake of 10,469 shares — an estimated $2.06M sold.

Point72 Middle East FZE first reported a position in LH in Q4 2022 and held it in 2 quarters. The position peaked at $5.36M in Q4 2022. 933 funds tracked by Wall St. Rank hold LH as of Q2 2023.

Point72 Middle East FZE reported no remaining Labcorp position as of Q2 2023 after selling out during the quarter.
Point72 Middle East FZE sold 10,469 Labcorp shares in Q2 2023, an estimated $2.06M.
Point72 Middle East FZE first reported a position in Labcorp in Q4 2022 and held it in 2 quarters.
Point72 Middle East FZE's Labcorp position peaked at $5.36M in Q4 2022.
933 funds tracked by Wall St. Rank held Labcorp as of Q2 2023.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.